MANKIND PHARMA
|
MANKIND PHARMA Last 5 Year Balance Sheet History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹40 Cr |
Equity - Authorised | ₹41 Cr | ₹41 Cr | ₹41 Cr | ₹41 Cr | ₹41 Cr |
Equity - Issued | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹40 Cr |
Equity Paid Up | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹40 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 |
Share Warrants & Outstandings | ₹0.06 Cr | - | - | - | - |
Total Reserves | ₹7,395 Cr | ₹6,115 Cr | ₹4,682 Cr | ₹3,445 Cr | ₹2,783 Cr |
Securities Premium | ₹42 Cr | ₹42 Cr | ₹42 Cr | ₹42 Cr | ₹42 Cr |
Capital Reserves | ₹-909 Cr | ₹-909 Cr | ₹-909 Cr | ₹-909 Cr | ₹-909 Cr |
Profit & Loss Account Balance | ₹8,012 Cr | ₹6,735 Cr | ₹5,304 Cr | ₹4,065 Cr | ₹3,408 Cr |
General Reserves | ₹238 Cr | ₹238 Cr | ₹238 Cr | ₹238 Cr | ₹238 Cr |
Other Reserves | ₹12 Cr | ₹9.11 Cr | ₹7.56 Cr | ₹8.91 Cr | ₹4.49 Cr |
Reserve excluding Revaluation Reserve | ₹7,395 Cr | ₹6,115 Cr | ₹4,682 Cr | ₹3,445 Cr | ₹2,783 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹7,435 Cr | ₹6,155 Cr | ₹4,722 Cr | ₹3,485 Cr | ₹2,823 Cr |
Minority Interest | ₹188 Cr | ₹161 Cr | ₹141 Cr | ₹186 Cr | ₹159 Cr |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹23 Cr | ₹49 Cr | ₹57 Cr | ₹58 Cr | ₹25 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹45 Cr | ₹67 Cr | ₹69 Cr | ₹49 Cr | ₹22 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹-22 Cr | ₹-18 Cr | ₹-11 Cr | ₹9.14 Cr | ₹3.28 Cr |
Unsecured Loans | - | ₹0.25 Cr | ₹0.25 Cr | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | ₹0.25 Cr | ₹0.25 Cr | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹48 Cr | ₹16 Cr | ₹-36 Cr | ₹-40 Cr | ₹-6.57 Cr |
Deferred Tax Assets | ₹315 Cr | ₹228 Cr | ₹193 Cr | ₹149 Cr | ₹87 Cr |
Deferred Tax Liability | ₹362 Cr | ₹244 Cr | ₹157 Cr | ₹109 Cr | ₹80 Cr |
Other Long Term Liabilities | ₹31 Cr | ₹23 Cr | ₹13 Cr | ₹22 Cr | ₹14 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹98 Cr | ₹80 Cr | ₹72 Cr | ₹63 Cr | ₹45 Cr |
Total Non-Current Liabilities | ₹199 Cr | ₹169 Cr | ₹107 Cr | ₹103 Cr | ₹78 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹1,008 Cr | ₹1,076 Cr | ₹667 Cr | ₹745 Cr | ₹562 Cr |
Sundry Creditors | ₹1,008 Cr | ₹1,076 Cr | ₹667 Cr | ₹745 Cr | ₹562 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹386 Cr | ₹473 Cr | ₹283 Cr | ₹180 Cr | ₹117 Cr |
Bank Overdraft / Short term credit | - | ₹11 Cr | ₹39 Cr | ₹2.58 Cr | ₹0.08 Cr |
Advances received from customers | ₹26 Cr | ₹17 Cr | ₹12 Cr | ₹4.09 Cr | ₹3.21 Cr |
Interest Accrued But Not Due | - | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | ₹1.14 Cr | - |
Other Liabilities | ₹360 Cr | ₹446 Cr | ₹231 Cr | ₹172 Cr | ₹113 Cr |
Short Term Borrowings | ₹115 Cr | ₹795 Cr | ₹158 Cr | ₹44 Cr | ₹241 Cr |
Secured ST Loans repayable on Demands | ₹115 Cr | ₹731 Cr | ₹148 Cr | ₹35 Cr | ₹232 Cr |
Working Capital Loans- Sec | ₹115 Cr | ₹731 Cr | ₹148 Cr | ₹35 Cr | ₹232 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-115 Cr | ₹-668 Cr | ₹-139 Cr | ₹-27 Cr | ₹-222 Cr |
Short Term Provisions | ₹354 Cr | ₹280 Cr | ₹245 Cr | ₹281 Cr | ₹104 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹46 Cr | ₹15 Cr | ₹11 Cr | ₹66 Cr | ₹1.08 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹308 Cr | ₹265 Cr | ₹234 Cr | ₹216 Cr | ₹103 Cr |
Total Current Liabilities | ₹1,863 Cr | ₹2,623 Cr | ₹1,353 Cr | ₹1,251 Cr | ₹1,024 Cr |
Total Liabilities | ₹9,686 Cr | ₹9,108 Cr | ₹6,324 Cr | ₹5,025 Cr | ₹4,084 Cr |
ASSETS | |||||
Gross Block | ₹5,233 Cr | ₹4,247 Cr | ₹2,160 Cr | ₹1,988 Cr | ₹1,681 Cr |
Less: Accumulated Depreciation | ₹984 Cr | ₹664 Cr | ₹501 Cr | ₹373 Cr | ₹282 Cr |
Less: Impairment of Assets | ₹3.87 Cr | - | - | ₹21 Cr | - |
Net Block | ₹4,245 Cr | ₹3,583 Cr | ₹1,659 Cr | ₹1,594 Cr | ₹1,399 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹493 Cr | ₹670 Cr | ₹372 Cr | ₹313 Cr | ₹327 Cr |
Non Current Investments | ₹271 Cr | ₹235 Cr | ₹206 Cr | ₹164 Cr | ₹216 Cr |
Long Term Investment | ₹271 Cr | ₹235 Cr | ₹206 Cr | ₹164 Cr | ₹216 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹325 Cr | ₹285 Cr | ₹263 Cr | ₹164 Cr | ₹216 Cr |
Long Term Loans & Advances | ₹188 Cr | ₹164 Cr | ₹158 Cr | ₹106 Cr | ₹118 Cr |
Other Non Current Assets | ₹99 Cr | ₹13 Cr | ₹17 Cr | ₹16 Cr | ₹14 Cr |
Total Non-Current Assets | ₹5,358 Cr | ₹4,702 Cr | ₹2,417 Cr | ₹2,203 Cr | ₹2,085 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹1,075 Cr | ₹874 Cr | ₹1,306 Cr | ₹665 Cr | ₹543 Cr |
Quoted | ₹1,075 Cr | ₹874 Cr | ₹1,306 Cr | ₹665 Cr | ₹543 Cr |
Unquoted | - | - | - | - | - |
Inventories | ₹1,498 Cr | ₹1,760 Cr | ₹1,184 Cr | ₹899 Cr | ₹821 Cr |
Raw Materials | ₹414 Cr | ₹399 Cr | ₹284 Cr | ₹233 Cr | ₹177 Cr |
Work-in Progress | ₹86 Cr | ₹94 Cr | ₹73 Cr | ₹72 Cr | ₹57 Cr |
Finished Goods | ₹285 Cr | ₹310 Cr | ₹224 Cr | ₹136 Cr | ₹92 Cr |
Packing Materials | - | - | - | - | - |
Stores Ā and Spare | ₹35 Cr | ₹24 Cr | ₹12 Cr | ₹9.38 Cr | ₹6.21 Cr |
Other Inventory | ₹678 Cr | ₹934 Cr | ₹591 Cr | ₹449 Cr | ₹489 Cr |
Sundry Debtors | ₹576 Cr | ₹388 Cr | ₹331 Cr | ₹531 Cr | ₹220 Cr |
Debtors more than Six months | ₹21 Cr | ₹15 Cr | ₹10 Cr | - | - |
Debtors Others | ₹575 Cr | ₹385 Cr | ₹325 Cr | ₹535 Cr | ₹220 Cr |
Cash and Bank | ₹453 Cr | ₹406 Cr | ₹701 Cr | ₹420 Cr | ₹141 Cr |
Cash in hand | ₹0.46 Cr | ₹0.25 Cr | ₹0.19 Cr | ₹0.26 Cr | ₹0.26 Cr |
Balances at Bank | ₹453 Cr | ₹403 Cr | ₹701 Cr | ₹400 Cr | ₹141 Cr |
Other cash and bank balances | - | ₹2.29 Cr | - | ₹19 Cr | ₹0.01 Cr |
Other Current Assets | ₹105 Cr | ₹171 Cr | ₹83 Cr | ₹10 Cr | ₹8.49 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹33 Cr | ₹136 Cr | ₹37 Cr | ₹9.50 Cr | ₹8.07 Cr |
Other current_assets | ₹72 Cr | ₹35 Cr | ₹46 Cr | ₹0.66 Cr | ₹0.43 Cr |
Short Term Loans and Advances | ₹616 Cr | ₹804 Cr | ₹276 Cr | ₹294 Cr | ₹209 Cr |
Advances recoverable in cash or in kind | ₹37 Cr | ₹73 Cr | ₹39 Cr | ₹42 Cr | ₹26 Cr |
Advance income tax and TDS | - | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹579 Cr | ₹731 Cr | ₹237 Cr | ₹253 Cr | ₹183 Cr |
Total Current Assets | ₹4,325 Cr | ₹4,404 Cr | ₹3,880 Cr | ₹2,820 Cr | ₹1,943 Cr |
Net Current Assets (Including Current Investments) | ₹2,461 Cr | ₹1,780 Cr | ₹2,526 Cr | ₹1,569 Cr | ₹919 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹9,686 Cr | ₹9,108 Cr | ₹6,324 Cr | ₹5,025 Cr | ₹4,084 Cr |
Contingent Liabilities | ₹55 Cr | ₹83 Cr | ₹35 Cr | ₹242 Cr | ₹361 Cr |
Total Debt | ₹163 Cr | ₹868 Cr | ₹235 Cr | ₹128 Cr | ₹270 Cr |
Book Value | 185.61 | 153.65 | 117.88 | 87.00 | 70.47 |
Adjusted Book Value | 185.61 | 153.65 | 117.88 | 87.00 | 70.47 |
Compare Balance Sheet of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹94,782.0 Cr | -0.4% | 6% | NA | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,452.0 Cr | 2.6% | -4.7% | 54.7% | Stock Analytics | |
CIPLA | ₹113,132.0 Cr | 4.4% | -4.4% | 54.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,191.0 Cr | 5.8% | 17.7% | 24.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,512.0 Cr | 5.7% | 2.7% | 29.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,954.5 Cr | 0.4% | -5.4% | 82.7% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -0.4% |
6% |
|
SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses